Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 231

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 231
---
209 Benefit expense$123,705 $— $10,610 $10,610 $35 $(10,020)$124,330 Cost of products sold— 31,588 — 31,588 — (14,295)17,293 Operating expense17,9782722,8573,1291,488(2,508)20,087Operating gain (loss)$6,888 $1,975 $680 $2,655 $(1,044)$— $8,499 Year Ended December 31, 2022 Premiums$131,964 $— $1,499 $1,499 $— $(234)$133,229 Product revenue— 14,978 — 14,978 — — 14,978 Service fees6,520 — 889 889 44 — 7,453 Operating revenue - unaffiliated138,484 14,978 2,388 17,366 44 (234)155,660 Operating revenue - affiliated— 13,548 10,472 24,020 355 (24,375)— Operating revenue - total$138,484 $28,526 $12,860 $41,386 $399 $(24,609)$155,660 Benefit expense$115,869 $— $9,667 $9,667 $39 $(8,933)$116,642 Cost of products sold— 26,544 — 26,544 — (13,509)13,035 Operating expense16,5931142,6582,772502(2,167)17,700Operating gain (loss)$6,022 $1,868 $535 $2,403 $(142)$— $8,283  

 -132-

Elevance Health, Inc.Notes to Consolidated Financial Statements (continued)

A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the years ended December 31, 2024, 2023 and 2022 is as follows:202420232022Reportable segments’ operating revenues$175,204 $170,209 $155,660 Net investment income2,051 1,825 1,485 Net losses